JKJoel K. Kelso

Joel K. Kelso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joel K. Kelso has a total of 51 co-authors. Here are the top co-authors by number of shared publications:

  • George J. Milne

    University of Western Australia, Crawley, Australia

    24 shared publications
  • Nilimesh Halder

    School of Computer Science and Software Engineering, University of Western Australia, Perth, WA, Australia

    5 shared publications
  • Nilimesh Halder

    School of Computer Science and Software Engineering, University of Western Australia, Perth, Australia

    4 shared publications
  • Nilimesh Halder

    School of Computer Science and Software Engineering, University of Western Australia, Perth, Australia

    3 shared publications
  • Cheryl Cohen

    Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, a division of the National Health Laboratory Service, Johannesburg, South Africa; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    2 shared publications
  • Drew Mellor

    ASchool of Computer Science and Software Engineering, University of Western Australia, M002, 35 Stirling Highway, Crawley, WA 6009, Australia

    2 shared publications

Latest Publications

  • Open Access

    Where to prescribe burn: the costs and benefits of prescribed burning close to houses

    by Veronique Florec, Michael Burton, David Pannell, Joel Kelso, George Milne

    Prescribed burning is used in Australia as a tool to manage fire risk and protect assets. A key challenge is deciding how to arrange the burns to generate the highest benefits to society. Studies have shown that prescribed burning in the wildland–urban interface (WUI) can reduce the risk of house loss due to wildfires, but the costs and benefits of different arrangements for prescribed burning treatments have rarely been estimated. In this study, we use three different models to explore the costs and benefits of modifying the spatial arrangement of prescribed burns on public land, using the south-west of Western Australia as a case study. We simulate two hypothetical scenarios: landscape treatments and WUI treatments. We evaluate the long-term costs and benefits of each scenario and compare the results from the three models, highlighting the management implications of each model. Results indicate that intensifying prescribed burning treatments in public land in the WUI achieves a greater reduction in damages compared with applying the majority of the treatments in rural areas. However, prescribed burning in the WUI is significantly more expensive and, despite additional benefits gained from this strategy, in most cases it is not the most economically efficient strategy.


  • Open Access

    The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia

    by Pieter T. de Boer, Joel K. Kelso, Nilimesh Halder, Thi-Phuong-Lan Nguyen, Jocelyn Moyes, Cheryl Cohen, Ian G. Barr, Maarten J. Postma, George J. Milne


  • Open Access

    The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

    by Stefan Flasche, Mark Jit, Isabel Rodríguez-Barraquer, Laurent Coudeville, Mario Recker, Katia Koelle, George Milne, Thomas J Hladish, T Alex Perkins, Derek A T Cummings, et al.

    Large Phase III trials across Asia and Latin America have recently demonstrated the efficacy of a recombinant, live-attenuated dengue vaccine (Dengvaxia) over the first 25 mo following vaccination. Subsequent data collected in the longer-term follow-up phase, however, have raised concerns about a potential increase in hospitalization risk of subsequent dengue infections, in particular among young, dengue-naïve vaccinees. We here report predictions from eight independent modelling groups on the long-term safety, public health impact, and cost-effectiveness of routine vaccination with Dengvaxia in a range of transmission settings, as characterised by seroprevalence levels among 9-y-olds (SP9). These predictions were conducted for the World Health Organization to inform their recommendations on optimal use of this vaccine. The models adopted, with small variations, a parsimonious vaccine mode of action that was able to reproduce quantitative features of the observed trial data. The adopted mode of action assumed that vaccination, similarly to natural infection, induces transient, heterologous protection and, further, establishes a long-lasting immunogenic memory, which determines disease severity of subsequent infections. The default vaccination policy considered was routine vaccination of 9-y-old children in a three-dose schedule at 80% coverage. The outcomes examined were the impact of vaccination on infections, symptomatic dengue, hospitalised dengue, deaths, and cost-effectiveness over a 30-y postvaccination period. Case definitions were chosen in accordance with the Phase III trials. All models predicted that in settings with moderate to high dengue endemicity (SP9 ≥ 50%), the default vaccination policy would reduce the burden of dengue disease for the population by 6%–25% (all simulations: –3%–34%) and in high-transmission settings (SP9 ≥ 70%) by 13%–25% (all simulations: 10%– 34%). These endemicity levels are representative of the participating sites in both Phase III trials. In contrast, in settings with low transmission intensity (SP9 ≤ 30%), the models predicted that vaccination could lead to a substantial increase in hospitalisation because of dengue. Modelling reduced vaccine coverage or the addition of catch-up campaigns showed that the impact of vaccination scaled approximately linearly with the number of people vaccinated. In assessing the optimal age of vaccination, we found that targeting older children could increase the net benefit of vaccination in settings with moderate transmission intensity (SP9 = 50%). Overall, vaccination was predicted to be potentially cost-effective in most endemic settings if priced competitively. The results are based on the assumption that the vaccine acts similarly to natural infection. This assumption is consistent with the available trial results but cannot be directly validated in the absence of additional data. Furthermore, uncertainties remain regarding the level of protection provided against disease versus infection and the rate at which vaccine-induced protection declines. Dengvaxia has the potential to reduce the burden of dengue disease in areas of moderate to high dengue endemicity. However, the potential risks of vaccination in areas with limited exposure to dengue as well as the local costs and benefits of routine vaccination are important considerations for the inclusion of Dengvaxia into existing immunisation programmes. These results were important inputs into WHO global policy for use of this licensed dengue vaccine.


  • Open Access

    Trivalent and quadrivalent influenza vaccination effectiveness in Australia and South Africa: results from a modelling study

    by George J. Milne, Nilimesh Halder, Joel K. Kelso, Ian G. Barr, Jocelyn Moyes, Kathleen Kahn, Rhian Twine, Cheryl Cohen

    Background: A modelling study was conducted to determine the effectiveness of trivalent (TIV) and quadrivalent (QIV) vaccination in South Africa and Australia.Objectives: This study aimed to determine the potential benefits of alternative vaccination strategies which may depend on community‐specific demographic and health characteristics.Methods: Two influenza A and two influenza B strains were simulated using individual‐based simulation models representing specific communities in South Africa and Australia over 11 years. Scenarios using TIV or QIV, with alternative prioritisation strategies and vaccine coverage levels, were evaluated using a country‐specific health outcomes process.Results: In South Africa, approximately 18% fewer deaths and hospitalisations would be expected to result from the use of QIV compared to TIV over the 11 modelled years (P = 0·031). In Australia, only 2% (P = 0·30) fewer deaths and hospitalisations would result. Vaccinating 2%, 5%, 15% or 20% of the population with TIV using a strategy of prioritising vulnerable age groups, including HIV‐positive individuals, resulted in reductions in hospitalisations and mortality of at least 7%, 18%, 57% and 66%, respectively, in both communities.Conclusions: The degree to which QIV can reduce health burden compared to TIV is strongly dependent on the number of years in which the influenza B lineage in the TIV matches the circulating B lineages. Assuming a moderate level of B cross‐strain protection, TIV may be as effective as QIV. The choice of vaccination prioritisation has a greater impact than the QIV/TIV choice, with strategies targeting those most responsible for transmission being most effective.


  • Techniques for evaluating wildfire simulators via the simulation of historical fires using the Australis simulator

    by Joel K. Kelso, Drew Mellor, Mary E. Murphy, George J. Milne

    A methodology for validating fire spread simulation systems using historical fire data is presented. The key features of this methodology are (a) quantitative comparison between simulator-generated fire perimeters and fire perimeters from an independently produced fire reconstruction at multiple time points during the fire, and (b) extensive sensitivity analyses on simulation variables including simulation spatial resolution, weather, vegetation coverage and fire behaviour model selection to determine the effect of each simulation input on the simulation output. The methodology is demonstrated in a case study in which the ability of the Australis high-performance wildfire simulator to replicate a large wildfire in Western Australia was examined. Simulation accuracy was found to be lower in extreme fire danger conditions and exhibited under-prediction of the head fire rate of spread. This was caused by inaccuracies in at least one of wind speed data, vegetation data or the fire behaviour model applied; however, the source of the inaccuracy could not be further diagnosed with the available data. The gathering of accurate data during and after active wildfires would facilitate more rigorous simulator and fire behaviour model validation studies as well as more accurate prediction of ‘live’ wildfires.


  • Open Access

    A spatial simulation model for dengue virus infection in urban areas

    by Stephan Karl, Nilimesh Halder, Joel K Kelso, Scott A Ritchie, George J Milne

    The World Health Organization estimates that the global number of dengue infections range between 80–100 million per year, with some studies estimating approximately three times higher numbers. Furthermore, the geographic range of dengue virus transmission is extending with the disease now occurring more frequently in areas such as southern Europe. Ae. aegypti, one of the most prominent dengue vectors, is endemic to the far north-east of Australia and the city of Cairns frequently experiences dengue outbreaks which sometimes lead to large epidemics. A spatially-explicit, individual-based mathematical model that accounts for the spread of dengue infection as a result of human movement and mosquito dispersion is presented. The model closely couples the four key sub-models necessary for representing the overall dynamics of the physical system, namely those describing mosquito population dynamics, human movement, virus transmission and vector control. Important features are the use of high quality outbreak data and mosquito trapping data for calibration and validation and a strategy to derive local mosquito abundance based on vegetation coverage and census data. The model has been calibrated using detailed 2003 dengue outbreak data from Cairns, together with census and mosquito trapping data, and is shown to realistically reproduce a further dengue outbreak. The simulation results replicating the 2008/2009 Cairns epidemic support several hypotheses (formulated previously) aimed at explaining the large-scale epidemic which occurred in 2008/2009; specifically, while warmer weather and increased human movement had only a small effect on the spread of the virus, a shorter virus strain-specific extrinsic incubation time can explain the observed explosive outbreak of 2008/2009. The proof-of-concept simulation model described in this study has potential as a tool for understanding factors contributing to dengue spread as well as planning and optimizing dengue control, including reducing the Ae. aegypti vector population and for estimating the effectiveness and cost-effectiveness of future vaccination programmes. This model could also be applied to other vector borne viral diseases such as chikungunya, also spread by Ae. aegypti and, by re-parameterisation of the vector sub-model, to dengue and chikungunya viruses spread by Aedes albopictus.


  • Open Access

    A Spatial Simulation Model for the Dispersal of the Bluetongue Vector Culicoides brevitarsis in Australia

    by Joel K Kelso, George J Milne

    The spread of Bluetongue virus (BTV) among ruminants is caused by movement of infected host animals or by movement of infected Culicoides midges, the vector of BTV. Biologically plausible models of Culicoides dispersal are necessary for predicting the spread of BTV and are important for planning control and eradication strategies. A spatially-explicit simulation model which captures the two underlying population mechanisms, population dynamics and movement, was developed using extensive data from a trapping program for C. brevitarsis on the east coast of Australia. A realistic midge flight sub-model was developed and the annual incursion and population establishment of C. brevitarsis was simulated. Data from the literature was used to parameterise the model. The model was shown to reproduce the spread of C. brevitarsis southwards along the east Australian coastline in spring, from an endemic population to the north. Such incursions were shown to be reliant on wind-dispersal; Culicoides midge active flight on its own was not capable of achieving known rates of southern spread, nor was re-emergence of southern populations due to overwintering larvae. Data from midge trapping programmes were used to qualitatively validate the resulting simulation model. The model described in this paper is intended to form the vector component of an extended model that will also include BTV transmission. A model of midge movement and population dynamics has been developed in sufficient detail such that the extended model may be used to evaluate the timing and extent of BTV outbreaks. This extended model could then be used as a platform for addressing the effectiveness of spatially targeted vaccination strategies or animal movement bans as BTV spread mitigation measures, or the impact of climate change on the risk and extent of outbreaks. These questions involving incursive Culicoides spread cannot be simply addressed with non-spatial models.


  • Open Access

    A model-based economic analysis of pre-pandemic influenza vaccination cost-effectiveness

    by Nilimesh Halder, Joel K Kelso, George J Milne

    A vaccine matched to a newly emerged pandemic influenza virus would require a production time of at least 6 months with current proven techniques, and so could only be used reactively after the peak of the pandemic. A pre-pandemic vaccine, although probably having lower efficacy, could be produced and used pre-emptively. While several previous studies have investigated the cost effectiveness of pre-emptive vaccination strategies, they have not been directly compared to realistic reactive vaccination strategies.


  • Evaluating wildfire simulators using historical fire data

    by George J. Milne, Joel K. Kelso, Drew Mellor, Mary E. Murphy